NKGEN news

Latest 2 stories · newest Jun 2, 2026

NKGEN

NKGen Biotech secures $2.42M additional convertible funding from AlpineBrook

NKGen Biotech amended its secured convertible loan agreement to receive $2.42 million in additional funding from AlpineBrook Capital, with new warrant issuance. The financing extension demonstrates continued investor support for the biotech company's capital needs.

Offering Jun 2, 2026 sentiment +0.50 SEC filing ↗

NKGEN

NKGen Biotech secures $412,500 additional convertible funding from AlpineBrook Capital

NKGen Biotech and its operating subsidiary amended their secured convertible loan agreement to receive an additional $412,500 in funding from AlpineBrook Capital GP I Limited, with the lender receiving additional consideration shares and warrants. The capital injection suggests the biotech company i…

Offering May 21, 2026 sentiment +0.30 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same NKGEN feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/NKGEN/newsSTART FREE